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Reactive oxygen speciesTumor-suppressive miR-34a, a direct target of p53, has been shown to target several molecules of
cell survival pathways. Here, we show that capsaicin-induced oxidative DNA damage culminates
in p53 activation to up-regulate expression of miR-34a in non-small cell lung carcinoma (NSCLC)
cells. Functional analyses further indicate that restoration of miR-34a inhibits B cell lymphoma-2
(Bcl-2) protein expression to withdraw the survival advantage of these resistant NSCLC cells. In such
a proapoptotic cellular milieu, where drug resistance proteins are also down-regulated, p53-trans-
activated Bcl-2 associated X protein (Bax) induces apoptosis via the mitochondrial death cascade.
Our results suggest that p53/miR-34a regulatory axis might be critical in sensitizing drug-resistant
NSCLC cells.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Lung cancer is the most common form of cancer worldwide.
Non-small cell lung cancer (NSCLC) accounts for 80% of all lung
cancer cases and is typically associated with frequent development
of resistance towards chemotherapy. The fact that drug-resistance
during cancer therapy is often multifactorial, stemming from the
simultaneous activation of non-redundant signaling pathways,
[1] complicates the implementation of clinically useful strategies
for increasing the anti-neoplastic potential of anti-cancer drugs.Deﬁciency in apoptosis is considered to be a major cause of the
therapeutic resistance of NSCLC. Apoptosis is activated and inacti-
vated by a variety of genes. It is well accepted that the response to
cellular stress factors like DNA damage involves activation of tu-
mor suppressor p53, a sequence-speciﬁc transcription factor. Few
convincing evidences suggest reactive oxygen species (ROS) gener-
ation triggers activation of p53 [2]. The primary function of p53 is
to activate transcription of genes that contain p53-binding sites in
their promoters. Transcriptional targets of p53 include the proa-
poptotic B cell lymphoma-2 (Bcl-2) family member Bcl-2 associ-
ated X protein (Bax), which migrates to mitochondria from
cytosol in response to apoptotic signals, permeabilizes the outer
membrane, resulting in release of mitochondrial proteins such as
cytochrome c, AIF etc. into the cytosol or nucleus where they are
actively involved in the process of caspase activation and
protein/DNA degradation [3,4].
MicroRNAs (miRNAs), a class of 22 nt endogenous RNAs, are
important regulators of gene expression and have been
implicated in the regulation of critical processes that are
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and apoptosis [7]. Among the miRNAs, miR-34 family members
play important tumor suppressive roles, as they are directly
regulated by p53 and compose the p53 network [8,9]. MiR-34a
is a member of the miR-34 family, which is composed of miR-
34a, miR-34b and miR-34c. The miR-34a gene is located on chro-
mosome 1p36.22 in a region that has previously been associated
with various cancers [10]. More recently, the epigenetic inactiva-
tion of miR-34a has been identiﬁed in many common tumor types
(lung, breast, colon, kidney, bladder, pancreatic cancer and
melanoma) and also in cell lines derived from those tumors. Be-
sides p53 mutation or functional inhibition of the expression of
miR-34a, there is evidence that aberrant CpG methylation of the
miR-34a promoter can result in concomitant loss of miR-34a
expression [11]. The importance of miR-34a in cancer is now
ﬁrmly established and restoration of functional miR-34a can inhi-
bit various cancer cell growths and induce apoptosis. For exam-
ple, chemically synthesized miR-34a was shown to block tumor
growth in NSCLC in vivo [12] and over-expression of miR-34a in
bulk or puriﬁed CD44 (+ve) prostate cancer cells inhibited
clonogenic expansion, tumor regeneration and metastasis [13].
Likewise, transient expression of miR-34a in glioma strongly
inhibited in vivo glioma xenograft growth [14] and targeted
expression of miR-34a sensitized medulloblastoma cells to vari-
ous classes of chemotherapeutic agents, including mitomycin C
and cisplatin [15]. Currently, Bcl-2 has been identiﬁed as one of
the candidate target genes of the miR-34 family [8–10,16–18].
These results suggest that up-regulation or re-introduction of
miR-34a not only inhibits cell growth but also enhances the drug
sensitivity of tumor cells under both in vitro and in vivo condi-
tions. However, very little is known about the function of miR-
34a in human non-small cell lung carcinoma although the central
role of the p53 pathway in affecting prognosis and response to
chemotherapy is well acknowledged.
Considering the poor responsiveness of NSCLC cells to conven-
tional therapies, alternative therapeutic measures that trigger
programmed cell death or apoptosis selectively in cancer cells
might be beneﬁcial for efﬁcient elimination of these tumors.
Recently, scientiﬁc studies support dietary phytochemicals as
potent anti-cancer drug candidates. In this regard, the quest for
new therapeutic targets will be essential for improving thera
peutic intervention of NSCLC. Capsaicin (trans-8-methyl-N-vanil-
lyl-6-nonenamide), a vanilloid receptor agonist, is the major
pungent principle component found in chili peppers of the plant
genus Capsicum [19] has signiﬁcant anti-cancer chemopreventive
properties [20]. This alkaloid compound has an in vitro anti-pro-
liferative effect on SCLC [21], prostate [22,23], colon [24], gastric
[25], hepatic [26] and leukemic cancer cells [27] while leaving
normal cells unharmed [27,28]. Capsaicin extracts have been
expansively investigated for their effects on genotoxicity and
mutagenicity in vitro as well as in vivo, but the study results are
conﬂicting [29]. However, the mechanism underlying capsaicin-
induced NSCLC cell killing, in particular the collaborative
contribution of p53-miR34a, if any, is still the ‘‘Cinderella of
investigation’’.
In the present investigation, we show that capsaicin treat-
ment generates ROS and causes DNA damage thereby ulti-
mately leading to p53 activation in NSCLCs. Tumor suppressor
protein p53 then acts as a double sword by up-regulating
miR-34a in one hand and transactivating Bax on the other. Res-
toration of miR-34a inhibits Bcl-2 protein expression thereby
decreasing the survival advantage of these NSCLC cells and
creating a pro-apoptotic milieu in these cells. Under this condi-
tion mitochondrial death cascade is initiated by Bax culminat-
ing in apoptosis.2. Methods
2.1. Cell culture
Human lung cancer cell lines, A549 and H1299; and normal
lung ﬁbroblast WI-38 were obtained from NCCS, India. The cells
were routinely maintained in complete Dulbecco’s modiﬁed
Eagle’s medium or RPMI1640 medium supplemented with 10%
heat-inactivated fetal bovine serum (FBS), penicillin (100 units/
ml), and streptomycin (100 lg/ml) at 37 C in a humidiﬁed incuba-
tor containing 5% CO2. Cells were allowed to reach conﬂuency be-
fore use. Cells were maintained in an exponential growth phase for
all experiments. All cells were re-plated in fresh complete serum
free medium for 24 h prior to the experiments. Viable cell numbers
were determined by Trypan blue exclusion test.
2.2. Treatment of cells
Cells were serum-starved for 24 h and were treated with differ-
ent concentrations of capsaicin (Sigma, St. Louis, MO, USA) for
different time points to select the optimum dose and time required
for cancer cell apoptosis. However, the doses beyond 50 lM caused
death of WI-38 cells, restricting us to use 50 lM dose for further
studies. To understand the sequence of events leading to apoptosis,
A549 cells were pre-treated for 2 h with 20 lM each of the speciﬁc,
caspase-9 (z-LEHD-FMK), caspase-3 (Z-DEVD-FMK) and Pan-cas-
pase (Z-VAD-FMK) inhibitors (Calbiochem/ED chemicals, NJ).
A549 cells were treated with p53-mediated transactivation inhib-
itor piﬁthrin-a (30 lM; Sigma, St. Louis), ROS scavenger N-acetyl-
cysteine (NAC) (Sigma, St. Louis) and mitochondrial pore inhibitor
CsA (25 lM; Merck, Germany) for 1 h prior to treatment with
capsaicin.
2.3. Flow cytometry
For the determination of cell death, cells were stained with pro-
pidium iodide (PI) and Annexin-V-FITC (BD Pharmingen, CA) and
analyzed on ﬂow cytometer (FACS Callibur, BD Biosciences, CA).
Electronic compensation of the instrument was done to exclude
overlapping of the emission spectra. Total 10000 events were ac-
quired for analysis using CellQuest software (BD Biosciences, CA)
[30]. Annexin-V/PI-positive cells were regarded as apoptotic cells
[31]. For the determination of cell cycle phase distribution of nu-
clear DNA, Cycle TEST PLUS DNA reagent kit (BD Biosciences, CA)
was used. Histogram display of DNA content (x axis, PI-ﬂuores-
cence) versus counts has been displayed. CellQuest statistics was
employed to quantitate the data at different phases of the cell cycle
[32,33]. For the assessment of mitochondrial transmembrane po-
tential (MTP) loss, cells were incubated with 40 nM potential-sen-
sitive dye 3,3-dihexyloxacarbocyanine iodide (DiOC6, Merck,
Germany) for 15 min in the dark and ﬂuorescence of retained
DiOC6 was determined ﬂow cytometrically using CellQuest soft-
ware (BD Biosciences, CA).
2.4. Assessment of ROS
Intracellular ROS was measured using 20,70-dichlorodihydroﬂu-
orescein diacetate (DCFH-DA) from Sigma Chemical Co. (St. Louis,
MO) as previously described [33]. Cells were incubated for
20 min at 37 C in the dark with 10 lM of DCFHDA. DCF ﬂuores-
cence was measured ﬂowcytometrically (FACS Callibur, BD Biosci-
ences, CA) and subjected to analysis using Cell Quest software (BD
Bioscience, CA). The probe was excited at 488 nm and emission
was measured through a 530 nm band-pass ﬁlter. For confocal
microscopy a Leica ﬂuorescent microscope DM 900 was used to
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with DCFHDA. Digital images were captured with a cool (25 C)
charged coupled device (CCD) camera controlled with the Meta-
Morph software [34].
2.5. Fluorescence imaging
Chromatin condensation and nuclear fragmentation was ana-
lyzed microscopically using standard protocol. Brieﬂy, cells were
grown on cover slips, ﬁxed with 4% paraformaldehyde for
10 min, permeabilized with 0.1% TritonX-100 for 5 min and incu-
bated with 40,6-diamidino-2-phenylindole (DAPI; BD Pharmingen,
CA). The morphology of the cell nuclei was subsequently visualized
using a ﬂuorescence microscope to ascertain apoptotic cell death
(Leitz microscope ﬁtted with epiﬂuorescence illuminator through
a 60 aperture oil immersion lens, Carl Zeiss, Germany) [35]. To
study protein expression using ﬂuorescent imaging, cells grown
on a cover slip were ﬁxed with 4% para-formaldehyde and were
stained with anti-p53 antibody (Santa Cruz, CA), after permeabili-
zation with Triton X-100, followed by Cy3-conjugated secondary
antibody and visualized with confocal microscope (Carl Zeiss,
Germany).
2.6. Western blot analysis
To obtain whole cell lysates, cells were homogenized in lysis
buffer (20 mM HEPES, pH 7.5, 10 mM KCl, 1.5 mM MgCl2, 1 mM
Na–EDTA, 1 mM Na–EGTA and 1 mM DTT) supplemented with
protease and phosphatase inhibitor cocktails [32,33]. Mitochon-
drial and cytosolic fractions were prepared according to Lahiry
et al. [36]. For direct western blot analysis, a total of 50 lg of
protein was resolved using SDS–PAGE and transferred to nitrocel-
lulose membrane for western blotting using relevant antibodies,
i.e., antibodies against cleaved caspases, e.g., anti-caspase-8
(Calbiochem, MA), anti-caspase-9 (Calbiochem, MA), anti-cas-
pase-3 (Oncogene, MA), anti-p53, anti-p63, anti-p73, anti-phos-
pho-p53, anti-Bax, anti-Bcl-2, anti-cytochrome-c, anti-MRP1,
anti-XIAP, anti-cIAP-1, anti-cIAP-2 (Santa Cruz, CA) and anti-phos-
pho-H2AX (Cell signaling, MA). The protein of interest was visual-
ized by chemiluminescence (GE Biosciences, NJ) [33]. Equal protein
loading in cytosolic, nuclear and mitochondrial fractions were
veriﬁed using anti a-actin, anti-HistoneH1 and anti-MnSOD
antibodies respectively (Santa Cruz, CA).
2.7. RNA isolation and RT-PCR
Two micrograms of the total RNA extracted with Trizol reagent
(Invitrogen, CA) was reverse transcribed and subjected to PCR
using RTplus PCR system (eppendorf, Hamburg, Germany) and
GeneAmp PCR system 2720 (Applied Biosystems, CA). The resulting
cDNAs were ampliﬁed with primers speciﬁc for p53, GAPDH and
Bax. The primer sequences for p53 were 50-CCCACTCACCGTAC-
TAA-30 (forward) and 50-GTGGTTTCAAGGCCAGATGT-30 (reverse),
Bax were 50-TTTGCTTCAGGGTTTCATCC-30 (forward) and 50-CAGT
TGAAGTTGCCGTCAGA-30 (reverse) and GAPDH (internal standard)
were 50-CAGAACATCATCCCTGCCTCT-30 (forward) and 50-GCTTGA
CAAAGTGGTCGTTGAG-30 (reverse).
2.8. Chromatin immunoprecipitation
ChIP assays were carried out using a ChIP assay kit (Millipore,
Darmstadt), with some modiﬁcations of the manufacturer’s
instructions. Brieﬂy, 2  106 cells were ﬁxed with 1% formaldehyde
for 10 min at 37 C to cross-link the protein-DNA complexes. Then
they were harvested and washed twice with ice-cold PBS contain-
ing protease inhibitors. Cells were added to SDS lysis buffer andincubated on ice for 10 min. Cell lysates were sonicated to shear
the DNA to lengths between 200 and 1000 base pairs and then
centrifuged at 3000 rpm for 10 min at 4 C. The sonicated cell
supernatants were diluted 10-fold in ChIP dilution buffer and
pre-cleared with protein A-agarose/salmon sperm DNA for
30 min at 4 C with agitation. The supernatant was recovered after
pelleting the agarose by centrifugation and then incubated with
speciﬁc antibody against p53 and acetylated histone H4 for
overnight at 4 C. The Ab-protein-DNA complexes were collected
by adding proteinA-agarose/salmon sperm DNA for 1 h at 4 C with
rotation. Immunoprecipitated Ab-protein-DNA complexes were
washed according to described protocol [11]. Chromatin
complexes were eluted with freshly prepared extraction buffer
(1% SDS, 0.1 M NaHCO3). To reverse cross-links, 5 M NaCl was
added to each eluate, and then the solution was heated to 65 C
for 4 h. Proteins were digested with 10 mg/ml proteinase K for
1 h at 45 C, and DNA was recovered by phenol/chloroform extrac-
tion and ethanol precipitation. DNA fragments were ampliﬁed by
PCR. The sequences of the primers for the binding site of p53 on
Bax promoter were 50-CTC ATGCCTGTAATCCCAGC-30 (forward)
and 50-GCAGAGACCTGGATCTAGC-30 (reverse).
2.9. miRNA isolation and quantiﬁcation
miRNA was isolated using mirVana miRNA isolation kit (Ambi-
on, CA). In brief, the cells were lysed in a denaturing buffer and
then RNA was extracted using acid phenol:chloroform to remove
most of the DNA. Quantitative real-time PCR was done to quantify
the levels of speciﬁc miRNAs during various treatments. Quantita-
tive real time PCR was performed in Master cycler gradient (an
Applied Biosystems 7500 Sequence Detection System) using
SYBR-green Rox mix (ABgene, Epsom, United Kingdom). The
relative abundance of the speciﬁc miRNAs was normalized to
U6snRNA.
2.10. siRNA and miRNA transfections
Cells were transfected with 300 pmol of control-/p53-/Bax-siR-
NA (Santa Cruz, CA) using lipofectamine 2000 (Invitrogen, CA). The
mRNA and protein levels were estimated by reverse transcription-
PCR and immunoblotting as described earlier. In miR-34a
functional studies, cells were transfected with 40 nM of either
miR-34a mimic (Dharmacon, IL) or miR-34a anti-miR oligo (Ambi-
on, CA), using lipofectamine 2000 (Invitrogen, CA).
3. Results
3.1. Capsaicin induces apoptosis in non-small cell lung cancer cells
To obtain precise quantitative insights into the effects of capsa-
icin, we exposed wt p53-expressing NSCLC cells, A549, to increas-
ing concentrations of capsaicin, followed by the assessment of
residual cellular viability using Trypan blue exclusion test. Fig. 1a
depicts the dose- and time-dependent effects of capsaicin on
A549 cell death. In gist, capsaicin-treatment for 12 h induced
signiﬁcant cell death in a dose-dependent manner, however, since
concentrations beyond 50 lMwere toxic for normal lung ﬁbroblast
cells (WI-38) (Fig. 1b), further experiments were restricted to
50 lM of capsaicin. The signiﬁcant pro-apoptotic effect of capsaicin
was observed up to 24 h of treatment. However, signiﬁcant cell
death (20%) occurred at 12 h thereby restricting us to perform
our auxiliary experiments at this time point to understand the
early signaling events leading to apoptosis. Our next effort to
characterize the cell death mechanisms revealed capsaicin-in-
duced increase in A549 cell population at sub-G0/G1 phase
(Fig. 1c) thereby pointing towards the possibility of induction of
Fig. 1. Capsaicin induces NSCLC cell apoptosis in a dose-dependent manner. (a) Dose- (left panel) and time-dependent (right panel) apoptotic effects of capsaicin on A549
cells were scored by trypan blue exclusion test. (b) WI38 (normal lung ﬁbroblast) cells were treated with increasing doses of capsaicin for 12 h and percent cell death was
scored by trypan blue exclusion test. (c) Cell cycle phase distribution of nuclear DNA after capsaicin (50 lM) treatment was determined by ﬂow cytometry in A549 cells. (d)
Capsaicin (50 lM; 12 h) pre-treated A549 cells were subjected to Annexin-V-FITC/PI staining and were analyzed by ﬂow cytometry. (e) Nuclear blebbing in 50 lM capsaicin-
treated A549 cells is shown by DAPI staining (left panel). Apoptotic cells were counted and plotted graphically (right panel). Values are mean ± S.E.M. of three independent
experiments in each case or representative of typical experiment.
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validate these ﬁndings we analyzed the number of Annexin-V-po-
sitive A549 cells by ﬂow cytometry. Fig. 1d shows signiﬁcant
increase (23%) in number of Annexin-V-positive lung cancer cells
as a result of capsaicin treatment indicating apoptosis as the pri-
mary mode of cell death. Apoptotic A549 cells were also discerned
by DAPI staining, which exposed capsaicin-induced nuclear
fragmentation and nuclear membrane invagination that uniquely
typify apoptotic cells (Fig. 1e).
3.2. Capsaicin-induced NSCLC cell apoptosis is p53-dependent
Our Western blotting data revealed that while within 2 h of
capsaicin treatment, p53 was signiﬁcantly up-regulated in A549
cells (Fig. 2a), other members of p53 family, p63 and p73 remained
unchanged (Fig. 2b, upper panel). These ﬁndings nullify the involve-
ment of p63 and p73 in capsaicin-initiated apoptotic process. It is
well acknowledged that to circumvent diverse activities in
response to varied stress stimuli, p53 protein remains under tight
regulatory control of post translational modiﬁcations where phos-
phorylation is the key event controlling p53 functions [37,38]. Our
results of Fig. 2a revealed that among different genotoxic stress-in-
duced phosphorylation sites of p53, e.g., Ser-15, Ser-20 and Ser-33
residues [27], capsaicin induced phosphorylation only at the Ser-
15 residue of p53 in A549 cells. Confocal imaging (Fig. 2c), as well
as western blot (Fig. 2d) data showing translocation of p53
from cytosol to nucleus further conﬁrmed activated status ofaccumulated p53 in A549 cells upon capsaicin-treatment. The role
of p53 in capsaicin-mediated apoptosis was further validated by
silencing p53 in A549 cells by p53-siRNA prior to capsaicin treat-
ment. In these transfectants, capsaicin failed to induce any signiﬁ-
cant apoptosis thereby validating the indispensible role of
functional p53 in capsaicin-induced NSCLC apoptosis (Fig. 2e, left
panel). Moreover, capsaicin failed to exhibit any signiﬁcant
pro-apoptotic effect in p53-null lung cancer cell line H1299 under
similar conditions (Fig. 2e, right panel). These results conﬁrmed the
involvement of wild type p53 in capsaicin-induced apoptosis of
A549 cells and also justiﬁed the inefﬁciency of this phytochemical
in inducing apoptosis in p53-null H1299 cells (Fig. 2e).
3.3. Capsaicin-induced p53-dependent apoptosis of NSCLC
is a consequence of DNA damage
One of the events in drug-induced p53 activation and apoptosis
in cancer cells is the induction of a DNA damage response that is
characterized by the appearance of DNA damage foci or phospho-
H2AX (p-H2AX) foci [39,40]. Histone 2AX phosphorylation, a
marker of DNA damage, was assayed by western blot for further
conﬁrmation of the involvement of DNA damage in capsaicin-in-
duced apoptosis of A549 NSCLC cells. The DNA double strand break
(DSB) was, therefore, measured in terms of p-H2AX expression.
Fig. 2f displayed the western blot data of p-H2AX obtained till
12 h treatment with 50 lM of capsaicin. While control A549 cells
maintained low levels of p-H2AX expression, capsaicin-treated
Fig. 2. ROS generation triggers DNA damage and activates p53 to induce NSCLC cell apoptosis. (a) Capsaicin-treated A549 cells were examined for time-dependent (0–12 h)
variation in the expression proﬁles of p53 protein and phospho-p53 at Ser-15, Ser-20 and Ser-33 sites by western blot (upper panel) and the mRNA expression proﬁle of p53
by RT-PCR (lower panel). (b) A549 cells treated with capsaicin (50 lM) were examined for time-dependent (0–12 h) variation in the expression proﬁles of p63 and p73 by
Western blot analysis. (c) Nuclear localization of p53 in A549 cells after capsaicin treatment visualized by confocal microscopy (Magniﬁcation 40). Cells were stained for p53
(Cy3; red) and nucleus (DAPI; blue). (d) Expressions of p53 in nuclear and cytosolic fractions of A549 cells treated with/without capsaicin were determined by western blot
analysis. (e) A549 cells, transiently transfected with a non-targeting control siRNA (control-siRNA) or p53-siRNA, were examined for percent apoptosis after capsaicin-
treatment (P < 0.001) (left panel). The efﬁciency of transfection was assessed by evaluating the expression of p53 (inset). H1299 cells treated with capsaicin (50 lM) were
subjected to Annexin-V-FITC/PI binding and analyzed ﬂow cytometrically for the determination of percent apoptosis (right panel). (f) Capsaicin-treated A549 cells were
examined for time-dependent (0–12 h) variation in the expression proﬁle of phospho-H2AX by western blot analysis. (g) Capsaicin-treated (0–4 h) A549 cells were assessed
ﬂow cytometrically for ROS generation by measuring DCF-ﬂuorescence intensity and the data was represented by histogram overlay (left panel). ROS generation was
visualized by confocal microscopy after ﬁxation and permeabilization of control/capsaicin-treated A549 cells using DCF-ﬂuorescence measurement (right panel; green;
magniﬁcation 100). (h) Flow cytometric analysis of capsaicin-induced ROS production with/without NAC, a pharmacological inhibitor of ROS, was determined and
represented by histogram overlay. (i) A549 cells treated with/without NAC incubated in presence or absence of capsaicin were analyzed for expression of phospho-Ser 15-
p53. (j) In a parallel experiment, percent apoptosis was determined by Annexin-V-FITC/PI staining and represented graphically (P < 0.001). (k) Capsaicin-treated A549 cells
were examined for expression of phospho-H2AX with/without NAC treatment by western blot analysis. Values are mean ± S.E.M. of three independent experiments in each
case or representative of typical experiment. a-actin, histone H1 and GAPDH were used as internal loading control.
S. Chakraborty et al. / FEBS Letters 588 (2014) 549–559 553cells showed dramatic increase in p-H2AX expression within 2 h of
treatment clearly suggesting capsaicin-induced DNA damage in
these cells.
3.4. ROS generation triggers DNA damage and activates p53 to induce
NSCLC apoptosis
Previous studies have reported that capsaicin inhibits growth
and induces apoptosis in tumor cells along with generation of
ROS [27]. ROS-induced activation of p53 has also been noted in a
different study [41]. These reports, along with the above-furnished
results depicting DNA damage and p53 activation by capsaicin,
raised the possibility of involvement of ROS in capsaicin-inducedA549 cells apoptosis. Therefore, the regulating effects of intracellu-
lar ROS, if any, on p53 activation and apoptosis up on capsaicin
treatment was compared. The level of ROS generated was assessed
bymeasuring DCFDA ﬂuorescence after treatment with 50 lM cap-
saicin for varying time intervals. Results depict a gradual rise in
DCFDA ﬂuorescence that starts within 30 min of capsaicin treat-
ment (Fig. 2g, left panel). These results were supported by our con-
focal imaging data of capsaicin-treated A549 cells (Fig. 2g, right
panel). To authenticate the role of ROS in NSCLC apoptosis, A549
cells treated with ROS scavenger, NAC, prior to capsaicin treatment
not only blocked ROS generation (Fig. 2h) but also attenuated both
capsaicin-induced p53 activation (Fig. 2i) and apoptosis (Fig. 2j).
These results validate the involvement of ROS in capsaicin-induced
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which ROS precede p53 in this death pathway. Moreover, decrease
in p-H2AX level upon addition of NAC prior to capsaicin treatment
(Fig. 2k) re-conﬁrmed the lead role of ROS in capsaicin-induced
DNA damage in A549 cells. These observations indicate that capsa-
icin-induced DNA damage is dependent on the ROS generation.
3.5. Restoration of miR-34a expression by capsaicin decreases survival
advantage in non-small lung cancer cells
Emerging evidences suggest critical role of miR-34a, a pivotal
member of p53 network [40], in chemo-resistance and sensitivity.
Exploration in number of cancers describes Bcl-2 as a target of
miR-34a in cancer cells [8–10,16–18]. MiR-34a has been found
to be down-regulated in multiple types of tumors [10,11]. There-
fore, our next aim was to explore whether p53/miR-34a axis is
operative in capsaicin-induced A549 cell apoptosis. Intriguingly,
real-time PCR results demonstrate time-dependent up-regulation
in miR-34a transcript in capsaicin-treated A549 cells (Fig. 3a).
Further results showed a time-dependent decrease in Bcl-2 pro-
tein level with increase in miR-34a expression up on capsaicin-
treatment (Fig. 3b). To conﬁrm whether miR-34a is a bona ﬁde
p53 target in A549 cells, we checked its expression in p53-si-
lenced cells. Our results depict that p53 depletion signiﬁcantly
abrogated the effect of capsaicin on miR-34a expression suggest-
ing that miR-34a is a p53 target in capsaicin-treated A549 cells
(Fig. 3c; left panel). Interestingly, Bcl2 expression was up-regu-
lated upon p53-silencing even in presence of capsaicin, providing
survival beneﬁt to the p53-siRNA-transfected cells (Fig. 3c; right
panel). To validate the involvement of miR-34a in A549 cell apop-
tosis, we transfected A549 cells with miR-34a mimic or inhibitor
and assessed their effect on both capsaicin-mediated apoptosis
and Bcl-2 expression (Fig. 3d and e). While, A549 cells with lower
miR-34a expression displayed higher expression of Bcl-2 protein,
overexpression of exogenous miR-34a signiﬁcantly diminished
Bcl-2 expression (Fig. 3d); therefore, an inverse correlation is evi-
dent between the miR-34a level and Bcl-2 expression. Further
exploration revealed that over-expression of miR-34a augmented
capsaicin-induced apoptosis, while inhibition of miR-34a signiﬁ-
cantly favored survival beneﬁt by increasing Bcl-2 level (Fig. 3e).
It is noteworthy that reduction in percent apoptosis was more in
case of p53-silenced cells than anti-miR-34a treatment even in
the presence of capsaicin (Figs. 2e and 3e). Taken together, our
data demonstrated that p53-induced miR-34a targets Bcl-2 to
render the NSCLCs susceptible to apoptosis after capsaicin
treatment.
3.6. Validation of involvement of Bax in capsaicin-induced NSCLC cell
apoptosis
Afore-furnished results led to the conclusion that capsaicin in-
duces oxidative DNA damage to activate p53 that in turn up-regu-
lates miR-34a expression to down-regulate Bcl-2 protein and
thereby decrease the survival advantage of A549 cells. Therefore,
in an attempt to identify the molecule mediating capsaicin-in-
duced A549 cell apoptosis in such pro-death environment, we next
evaluated the role Bax, if any, since Bax is one of the direct tran-
scriptional targets of p53 through which p53 materializes its
apoptotic functions. Fig. 3f shows up-regulation of Bax at both
mRNA and protein levels after capsaicin-exposure. Notably, in
p53-siRNA transfected A549 cells, Bax expression at both protein
and mRNA levels was found to be down-regulated (Fig. 3f), with
consequent reduction in capsaicin-induced apoptosis among the
transfectants (Fig. 2e) thereby indicating the involvement of p53-
induced transactivation of Bax in capsaicin-mediated apoptosis.
However, capsaicin-induced Bax expression was independent ofmiR-34a status (data not shown). In an attempt to further validate
the role of Bax in capsaicin-induced NSCLC cell apoptosis, we
extraneously modulated its expression in A549 cells before capsa-
icin treatment. At this end, silencing of Bax by short-interfering
RNA (siRNA) signiﬁcantly abrogated capsaicin-induced apoptosis
in A549 cells (Fig. 3g). Bax-silencing signiﬁcantly abroagated cap-
saicin-induced apoptosis in these p53-up-regulated A549 cells
(Fig. 3g) suggesting that Bax is mainly responsible for inducing
apoptosis in these cells upon capsaicin-insult. To conﬁrm that
p53 transcriptional activation is indispensable for capsaicin-in-
duced A549 cell death, p53 transactivation inhibitor piﬁthrin-a
was used before capsaicin-treatment. Piﬁthrin-a signiﬁcantly pre-
vented capsaicin-induced increase in Bax mRNA and protein level
as well as apoptosis in A549 cells although there was increase in
p53 mRNA and protein levels (Fig. 3h). To validate the above ﬁnd-
ings we have monitored the status of p53 binding on the Bax pro-
moter following capsaicin and/or piﬁthrin-a treatment by ChIP
assays using anti-p53 antibody. Primers were designed from the
377 to 489 bp region which includes p53 binding consensus se-
quence at the 404 to 424 bp region on the Bax promoter fol-
lowed by an adjacent TATA box. Compared to untreated A549
cells, capsaicin treatment led to signiﬁcant p53 binding on Bax pro-
moter, while piﬁthrin-a decreased the same. In piﬁthrin-a pre-
treated cells capsaicin failed to exert its effect. Similar results have
been obtained when chromatin were immunoprecipitated with
anti-acetylated-H4 antibody. In fact, capsaicin treatment showed
noticeable induction of acetylated-H4 on the Bax promoter when
compared with control set whereas in piﬁthrin-a treated A549
cells, minimal/basal induction of H4 acetylation was there on the
Bax promoter and that remained unaltered up on capsaicin treat-
ment. These results conﬁrming that piﬁthrin-a inhibited cancer
cell apoptosis almost completely, negated the possibility of the
involvement of p53-dependent, transactivation-independent path-
way. Altogether, these ﬁndings are in accordance with our hypoth-
esis that capsaicin treatment leads to p53-mediated Bax
transactivation by binding to its promoter.
Altogether our ﬁndings revealed that capsaicin-induced resto-
ration of p53/miR-34a regulatory axis induces (i) miR-34a-medi-
ated down-regulation of Bcl-2, and (ii) p53-transactivation of
Bax, the resultant of which ensures apoptosis of A549 cells in this
cellular anti-survival micro-environment.
3.7. Capsaicin activates mitochondrial death cascade in the down-
stream to persuade apoptosis in NSCLC
Above results prompted us to evaluate the involvement of mito-
chondria, if any, in these capsaicin-treated A549 cell apoptosis. Our
Western blot data revealed translocation of Bax from cytosol to
mitochondria (Fig. 4a), pre-requisite for mitochondrial membrane
perturbation. Next, loss of mitochondrial transmembrane potential
(MTP) in terms of reduced DiOC6 binding in A549 cells after 12 h of
50 lM capsaicin, further conﬁrmed the involvement of mitochon-
dria in capsaicin-induced A549 cell apoptosis (Fig. 4b). Moreover,
capsaicin-induced MTP loss in A549 cells was accompanied by a
signiﬁcant decrease in cytochrome c level in mitochondria with
its simultaneous increase in the cytosol (Fig. 4a) thereby further
authenticating the involvement of mitochondrial death cascade
in capsaicin-induced A549 cell apoptosis.
3.8. Capsaicin activates caspases to execute A549 cell apoptosis
To map the execution phase of apoptosis, we checked the
involvement of caspases, if any, in capsaicin-induced A549 cell
apoptosis. Our effort to examine the expression of the initiator
caspases, caspase-8, caspase-9, and also the executioner caspase,
caspase-3, in capsaicin-exposed A549 cells demonstrated
Fig. 3. Restoration of p53-dependent miR-34a expression by capsaicin decreases survival advantage and promotes Bax-mediated apoptosis in A549 cells. (a) Capsaicin-
treated A549 cells were examined for time-dependent variation (0–12 h) in the expression proﬁles of miR-34a by qRT-PCR analysis and represented graphically (P < 0.01,
P < 0.001). (b) Capsaicin-treated A549 cells were examined for time-dependent variation (0–12 h) in the expression proﬁle of Bcl-2 by western blot analysis. (c) A549 cells,
transiently transfected with control-siRNA or p53-siRNA, after capsaicin treatment were examined for the expression of miR-34a evaluated by qRT-PCR and represented
graphically (P < 0.001) (left panel). Control/p53-siRNA transfected A549 cells were treated with capsaicin and examined for the expression proﬁles of Bcl-2 by western blot
(right panel). (d) A549 cells transfected with/without miR-34a mimic followed by capsaicin treatment were scored for percent cell death (P < 0.05; left panel). In a similar
experimental setup, expression level of Bcl-2 was determined by western blot (right panel). (e) A549 cells, transfected with/without miR-34a inhibitor followed by capsaicin
treatment, were scored for percent cell death (P < 0.05; left panel). In a similar experimental setup, expression level of Bcl-2 was determined by western blot (right panel). (f)
Capsaicin-treated A549 cells transfected with control/p53-siRNA were examined for the expression proﬁles of Bax by western blot (upper left panel) and RT-PCR (lower left
panel). Graphical representation of the densitometric analysis data of western blot (middle panel) and RT-PCR (right panel) for the relative Bax expression. (g) A549 cells,
transfected with control/Bax-siRNA or treated with piﬁthrin-a with/without capsaicin were scored for percent apoptosis (P < 0.001). The efﬁciency of Bax-siRNA transfection
was also veriﬁed (inset). (h) The expression levels of p53 and Bax with/without piﬁthrin-a in absence or presence of capsaicin were examined by western blot (upper panel)
and RT-PCR (lower panel) in A549 cells. (i) p53 binding to the Bax promoter following capsaicin/piﬁthrin-a treatment was analyzed by ChIP assay. Schematic representation of
the Bax promoter showing the p53 binding site (upper panel), PCR run with the primers designed from 489 to 377 bp. The immunoprecipitation was carried out with
antibodies speciﬁc for p53 (middle left panel) and acetylated HistoneH4 (lower left panel). Input and control IgG were used as internal control and negative control,
respectively. The relative abundance of p53 and acetylated H4 on Bax promoter was analyzed in control and capsaicin-treated A549 cells and represented graphically (middle
and lower right panel). Values are mean ± S.E.M. of three independent experiments performed individually. a-actin/GAPDH was used as internal loading control.
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Fig. 4. Capsaicin-induced A549 cell apoptosis involves mitochondrial-death cascade. (a) Expression of cytochrome c and Bax in mitochondria and cytosolic compartments of
A549 cells with/without capsaicin treatment were determined by western blot. (b) A549 cells were incubated with or without capsaicin (50 lM; 12 h) and were monitored
for mitochondrial transmembrane potential (MTP) loss by DiOC6-ﬂuorescence measurement using ﬂow cytometry. (c) Capsaicin-treated A549 cells were examined for time-
dependent (0–12 h) variation in the expression proﬁles of cleaved-caspases -8, -9 and -3 by western blot. (d) Expression proﬁles of cleaved-caspases-9 and -3 in A549 cells
were determined by western blot with/without application of the mitochondrial pore blocker Cyclosporin-A (CsA). (e) Caspase-8, -9 and -3 inhibitors/pan-caspase inhibitor
pretreated A549 cells, treated with/without capsaicin, were scored for percent apoptosis (P < 0.001) and represented graphically. (f) Capsaicin-treated A549 cells were
examined for time-dependent (0–12 h) variation in the expression proﬁles of MRP1, XIAP, cIAP-1 and cIAP-2 by western blot analysis. a-actin or MnSOD was used as internal
loading control. (g) Expression proﬁles of cleaved-caspases-9 and -3 by western blot after A549 cells transfected with control/p53-siRNA (left panel) and with/without miR-
34a inhibitor (right panel) followed by capsaicin treatment. (h) Expression proﬁles of MRP1, XIAP, cIAP-1 and cIAP-2 by western blot after A549 cells transfected with control/
p53-siRNA (left panel) and with/without miR-34a inhibitor (right panel). a-actin/MnSOD was used as internal loading control.
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with caspase-3 but not caspase-8 (Fig. 4c). Cyclosporin A (CsA), the
inhibitor of mitochondrial pore formation, completely blocked
activation of these caspases, while capsaicin-treatment could bring
about a reversal of this effect, indicating mitochondrial disruption
to be solely responsible for capsaicin-induced caspase activation
(Fig. 4d).
Requirement of caspase activity for capsaicin-induced apoptosis
was further validated by pre-treating the cells with cell permeable
inhibitor of caspase-9 (Z-LEHD-FMK) as well as of caspase-3 (Z-
DEVD-FMK), singularly or in combination prior to capsaicin-treat-
ment. Inhibition of either the initiator or the executioner caspase
completely abrogated capsaicin-mediated apoptosis in A549 cells
(Fig. 4e). Similar results were seen with pan caspase inhibitor
treatment wherein capsaicin-mediated apoptosis in A549 cells
was totally abrogated. These results altogether demonstrate that
capsaicin exerts its apoptogenic effect on A549 cells in caspase-9
and caspase-3 dependent manner. Next, in an attempt to under-
stand the relationship between p53/miR-34a expression and cas-
pase-activation, A549 cells were transfected with p53-siRNA and
miR-34a inhibitor and analyzed for caspase activation by western
blotting. Our results indicated signiﬁcant decrease in the levels ofcleaved caspase-9 and caspase-3 in p53-silenced cells even after
capsaicin treatment (Fig. 4g, left panel). However, in comparison
to p53-ablation, treatment with miR-34a inhibitor exhibited much
lesser effect on caspase-activation by capsaicin (Fig. 4g, right
panel).
3.9. Capsaicin decimates the multi-drug resistance and inhibitor
of apoptosis proteins
Since NSCLC cells are refractory to anti-cancer drugs, the mech-
anism underlying switching over of these cells from resistance to
apoptosis by capsaicin revealed that while untreated NSCLC cells
furnish high levels of principal drug resistance protein MRP1, as
well as inhibitor of apoptosis protein (IAP) family members, e.g.,
XIAP, cIAP-1, and cIAP, treatment with capsaicin signiﬁcantly
down-regulated these proteins in A549 cells (Fig. 4f). These results
justify as to why capsaicin treatment confers sensitivity to these
resistant A549 cells, which then undergo apoptosis via re-installa-
tion of p53/miR-34a axis. We have further analyzed the expression
of MRP1, XIAP, cIAP-1 and cIAP-2 in p53-siRNA transfected and
anti-miR-34a inhibitor-treated A549 cells. Results of Fig. 4h
depicted that p53 ablation or miR-34a inhibitor pre-treatment
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of MRP1, cIAP-1 and cIAP-2 (Fig. 4h). However, in p53-silenced
cells, but not in anti-miR-34a-treated ones, capsaicin was ineffec-
tive in reducing XIAP level (Fig. 4h). These results indicated the
existence of a p53/miR-34a-independent pathway of down-regula-
tion of MRP1, cIAP-1 and cIAP-2 by capsaicin, while that of XIAP-1
was p53-dependent but miR-34a-independent. Overall these ﬁnd-
ings indicated that in A549 cells, capsaicin-treatment down-regu-
lated drug-resistance and pro-survival factors, thereby creating a
pro-apoptotic environment in which induction of p53/miR-34a
axis ensured apoptosis.
In a nutshell these ﬁndings point towards the sensitivity of
drug-resistant NSCLCs to capsaicin via re-installation of p53/miR-
34a axis that sensitizes these cells to mitochondrial death cas-
cade-attributed apoptosis.
4. Discussion
Lung cancer is the leading cause of cancer deaths [42]. Even
with current advanced treatment, non-small cell lung cancer
(NSCLC) accounting for 80% of all lung cancer cases is reported to
have a 5-year survival rate of only 16% [42] that has not changed
appreciably over many decades [42]. This poor prognosis empha-
sizes the urgent need for the development of novel therapeutic ap-
proaches to more effectively manage this deadly disease. Previous
studies indicating that several lung cancer types show poor re-
sponse to presently available therapies, underscore the importance
for a better understanding of the molecular mechanisms thereby
identifying novel therapeutic targets and treatment modalities
for this deadly disease. Natural products are a vital resource for
the innovation of novel leads for cancer therapies. In this regard,
emerging evidence shows that capsaicin, the bio-active alkaloid
found in chili peppers of the plant genus Capsicum is a promising
anticancer agent that causes potent apoptosis in a variety of can-
cers [22–27]. Athanasiou et al. [28] found morphological changes
characteristic of apoptosis and/or necrosis in large cell lung cancer
cells like H460. However, there is no detail mechanistic study on
the apoptotic effects of capsaicin on non-small cell lung cancer
cells till date. Our results highlight that capsaicin could induce
apoptosis in NSCLC cells, A549, in a p53-dependent manner in
which p53, activated by ROS-induced DNA damage, trans-activated
Bax, the pro-apoptotic family member of Bcl-2. These results can
be supported by the previous ﬁndings by Choi et al. [43] where
they have shown that dihydrocapsaicin, an analogue of capsaicin,
successfully induced autophagy by accumulation of ROS in a cata-
lase-regulated manner [43]. Contribution of p53-transactivated
Bax in cancer cell apoptosis by various phytochemicals has already
been reported by various laboratories [35,36,44]. However, theFig. 5. Schematic diagram representing molecular mechanisms of capsaicin-induced N
survival advantage and ensures Bax-dependent cell death.resistant nature of NSCLC as well as its high probability of relapse
prompted us to extend our study in identifying more factors, if any,
which in collaboration with Bax shifted the cellular micro-environ-
ment from resistance to apoptosis up on capsaicin treatment.
Accumulating evidences reveal that pathogenesis of cancer is a
multistep process of sequential alterations in several, often many,
oncogenes, tumor-suppressor genes, or miRNAs in human cancers
including lung cancer [45,46]. Our literature search revealed that
miR-34a is transcriptionally induced by the tumor suppressor gene
p53, which is often down regulated in various human cancer types,
including lung cancer. miR-34a has been shown to be associated
with cancer cell proliferation and drug resistance through E2F in
colon cancer cells [47]. Recently, a study showed that NSCLC pa-
tients with upregulated miR-34a had better prognosis for survival
[48]. In addition, while low miR-34a expression level correlates
with a high probability of relapse in NSCLC patients [49]. Overex-
pression of the same miRNA induces apoptosis, senescence and cell
cycle arrest, and inhibits migration and invasion. In fact, miR-34a
not only displays an anti-proliferative phenotype in numerous can-
cer cell type, its ectopic expression inhibited cell growth and in-
duced apoptosis in NSCLC [50] suggesting that downstream of
the miR-34a pathway signals were sufﬁcient to induce apoptosis
and block NSCLC cell growth. However, so far, there is little under-
standing of how cellular miR-34a expression affects the response
of NSCLC cells to pro-apoptotic signals, and ultimately clinical out-
come. In this study, after ensuring capsaicin-induced up-regulation
and activation of p53 that resulted in Bax transactivation as de-
picted by elevated level of p53 binding and histone H4 acetylation
of the Bax promoter, we focused our attention to the status of miR-
34a in these capsaicin-treated NSCLC cells for restoration of p53/
miR-34a network as a result of which cells will switch over from
resistance to apoptosis thereby ﬁnally aiding in improving the clin-
ical outcome of this often-fatal cancer in future.
The key ﬁndings of the present study suggest that p53-induced
miR-34a plays an important role in NSCLC sensitization in response
to capsaicin-induced DNA damage. Our subsequent venture identi-
ﬁed Bcl-2 as the miR-34a target in these capsaicin-treated NSCLC
cells. Down-regulation of Bcl-2 created an anti-survival environ-
ment in these NSCLC cells that favored Bax-mediated apoptosis
via mitochondrial death cascade involving caspase-9 and -3, but
not caspase-8, thereby ruling out the involvement of extrinsic
death pathway. It is also accepted that p53-target miR-34a inhibits
SIRT1 thereby deacetylating and stabilizing p53 in a positive feed-
back loop [51]. It is thus tempting to speculate that miR-34
functions may play an important and broader role in NSCLC. Our
results indicate that p53 and miR-34a may act in concert in medi-
ating capsaicin-dependent effects in NSCLC (Fig. 5). Once these
associations are further conﬁrmed and clariﬁed, the focus couldSCLC cell apoptosis by restoration of p53/miR-34a regulatory axis that decreases
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through the p53 pathway, as a therapeutic intervention to re-
establish sensitivity to therapy.
However, the results discussed so far, while answering many
questions raised an important query. Since NSCLC cells are known
to be refractory to most of the chemotherapeutic drugs, activation
of p53/miR-34 axis may not provide complete answer as to how
these resistant cells surrendered to the pro-apoptotic micro-envi-
ronment of the cells. It is known that NSCLC cells are empowered
with a battery of multi-drug resistance and inhibitor of apoptosis
proteins that impart resistance to these non-small cell lung can-
cer cells [50]. Our venture to explore the status of these resis-
tance-imparting factors revealed down-modulation of the
principal drug resistance protein MRP1, as well as inhibitor of
apoptosis protein (IAP) family members, e.g., XIAP, cIAP-1, and
cIAP-2, in capsaicin-treated A549 cells. However, except XIAP,
whose expression was p53-dependent, effect of capsaicin on
these proteins was p53/miR-34a independent, the mechanism
of which is yet to be explored. These results all together led us
to the conclusion that capsaicin acted as a double-edged sword
by (i) depriving the cells from the resistance-imparting, pro-sur-
vival micro-environment, and (ii) simultaneously creating a
pro-apoptotic milieu to ﬁnally compel these otherwise resistant
non-small cell lung cancer cells for undergoing apoptosis. These
data suggest that capsaicin has the potential for therapy and
management of human NSCLCs.
5. Conclusions
To conclude, we have provided the proof-of-principle for sensi-
tization of resistant cancers like non-small cell lung carcinoma, by
capsaicin, a dietary phytochemical that features daily in our life.
Capsaicin, which activates p53-dependent apoptotic pathway
through miR-34a/Bcl-2/Bax interplay, may epitomize new avenues
for the successful treatment of lethal malignancies like non-small
cell lung carcinoma.
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